Lataa...
Trastuzumab (Herceptin)
Herceptin (trastuzumab) is a human monoclonal antibody that interferes with the HER2 receptor. It is currently the only FDA-approved therapeutic antibody for HER2-positive breast cancer. This article will present the mechanism at action as well as the clinical role at this monoclonal antibody.
Tallennettuna:
| Julkaisussa: | AJNR Am J Neuroradiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Neuroradiology
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964332/ https://ncbi.nlm.nih.gov/pubmed/21816914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2619 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|